HIGH-DOSE MELPHALAN (HDM) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR MYELOMA (MM) PATIENTS WITH SEVERE RENAL-FAILURE - PHARMACOKINETIC STUDY - CORRELATION BETWEEN BIOLOGY AND CLINICS

Authors
LIOURE B WIHLM J DIMITROV Y ABDELKEFI A MALOISEL F LIU KL LAPLACE A MOULIN B OBERLING F
Citation
B. Lioure et al., HIGH-DOSE MELPHALAN (HDM) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR MYELOMA (MM) PATIENTS WITH SEVERE RENAL-FAILURE - PHARMACOKINETIC STUDY - CORRELATION BETWEEN BIOLOGY AND CLINICS, Bone marrow transplantation, 21, 1998, pp. 705-705
Citations number
NO
Categorie Soggetti
Hematology,Oncology,Immunology,Transplantation
Journal title
Bone marrow transplantation → ACNP
ISSN journal
02683369
Volume
21
Year of publication
1998
Supplement
1
Pages
705 - 705
Database
ISI
SICI code
0268-3369(1998)21:<705:HM(AAS>2.0.ZU;2-I